HBIO
Harvard Bioscience
$5.99
−$0.01 (−0.17%)Jul 27, 2026
Key metrics
The numbers that frame HBIO today
- Market cap
- $27.02M
- P/E (TTM)
- -2.8
- EV / FCF
- 48.8
- Gross margin
- 58.4%
- EV / Sales
- 0.7
- ROIC
- -7.1%
- Div yield
- 0%
- Debt / equity
- 4.2
- 52wk Low
- $3.76
- 52wk High
- $9.40
Growth
Revenue and earnings trend for HBIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HBIO
Is Harvard Bioscience a good buy?
Yes. Harvard Bioscience has excellent quality and strong momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Harvard Bioscience is selling at a fair price.
What is the market capitalization of HBIO?
Harvard Bioscience's market capitalization is $27.02M.
What is the P/E ratio for HBIO stock?
Harvard Bioscience's current P/E ratio is -2.8.
What is the 52-week high for HBIO stock?
The 52-week high for Harvard Bioscience is $9.40. The current close of $5.99 is 36.3% below that high.
What is the 52-week low for HBIO stock?
The 52-week low for Harvard Bioscience is $3.76. The current close of $5.99 is 59.5% above that low.
Does HBIO stock pay dividends?
Harvard Bioscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HBIO?
Harvard Bioscience's Debt / Equity ratio is 4.24.